English Korean Chinese
ホーム > 市場調査レポート > 医薬品 > 糖尿病 > ケニアにおける糖尿病市場の戦略分析
カテゴリ
医薬品 (4964)
OTC (153)
がん (943)
ドラッグデリバリー (185)
ワクチン (181)
感染症 (353)
規制環境 (132)
後発医薬品 (135)
骨疾患 (37)
処方薬 (158)
神経疾患 (174)
精神疾患 (89)
製薬企業関連 (531)
創薬 (1524)
糖尿病 (193)
動物用医薬 (17)
肥満症 (44)
市場調査レポート

ケニアにおける糖尿病市場の戦略分析

Strategic Analysis of the Kenyan Diabetes Markets

発行 Frost & Sullivan
出版日 2008年04月 商品コード 64710
ページ情報 英文  
価格
US$ 7,500 換算 ¥ 603,525 (税抜) Web Access (Regional License)
US$ 8,000 換算 ¥ 643,760 (税抜) Hard Copy & Web Access (Regional License)


原文目次

Abstract

This Frost & Sullivan research service titled Strategic Analysis of the Kenyan Diabetes Markets provides an overview of the Kenyan healthcare industry in the context of diabetes treatment drugs as divided between type I and type II diabetics. In this research, Frost & Sullivan' s expert analysts thoroughly examine the key industry challenges, drivers, restraints and trends. Also provided are revenue forecasts and strategic recommendations.

This analysis is available through our Pharmaceuticals and Biotechnology Growth Partnership Services programme. With this programme, clients receive industry-leading market research such as this, along with technical and econometric data and many interactive features including Analyst Inquiry Time and Client Councils.

Table of Contents

  • 1. Executive Summary
  • 2. Research Objectives, Scope and Methodology
  • 3. Strategic Analysis of the Kenyan Diabetes Markets
  • 4. List of Key Industry Participants
  • 5. Decision Support Databases
Back to Top